pharmaphorum

APRIL 23, 2021

CRISPR Therapeutics is to receive a hefty $900m payment from Vertex after the companies amended a collaboration to develop, manufacture and market a gene editing therapy for sickle cell disease and beta thalassemia.

Gene Editing 64

Gene Editing Gene DNA Bacteria 64

pharmaphorum

MAY 7, 2021

Gene editing firm CRISPR Therapeutics has announced a collaboration with US biotech Nkarta to develop natural killer (NK) cell therapies for cancer. It’s at the forefront of gene editing although the technology has spawned rivals including Intellia Therapeutics, Caribou Biosciences, Sangamo Therapeutics and Mammoth Biosciences.

Gene Editing 52

Gene Editing Gene Genetic Engineering DNA 52

Roots Analysis

OCTOBER 11, 2023

Unlike conventional chemical pesticides, biopesticides may also involve beneficial microbial, such as insects and mollusks along with bacteria, fungi, or viruses, to target specific pests or pathogens, and mitigate their proliferation.

Production 40

Production Bacteria Marketing Gene Editing 40

The Pharma Data

DECEMBER 2, 2020

aeruginosa bacteria, instead of killing the bacteria as an antibiotic would aim to do. Tubulis – Germany’s Tubulis formed a strategic collaboration with WuXi STA and WuXi Biologics to manufacture and advance Tubulis’ next generation antibody-drug conjugates (ADCs) towards IND-enabling studies. Horizon Discovery Group – U.K.-based

Drugs 52

Drugs Gene Editing Genome Genomics 52

XTalks

AUGUST 2, 2023

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. every eight weeks for the 90 mg dose, according to the manufacturer. First FDA-approved in July 2017 for plaque psoriasis, the list price for a 30-day supply of Tremfya was stated to be $6,292, according to the manufacturer.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

DECEMBER 22, 2021

Formulas can be generated in days and clinical-grade manufacturing can be accomplished in weeks. The gene-editing tool CRISPR edits DNA using specialized strands of guide RNA and endogenous cellular mechanisms of RNA interference. They can be developed and adapted quickly. Minimally Invasive Devices.

Life Science 98

Life Science RNA Vaccination Vaccine 98

XTalks

DECEMBER 24, 2020

From rare disease drug approvals to treatments involving immunotherapies and gene therapies and awarding of a Nobel Prize to the inventors of the gene-editing tool CRISPR, 2020 was a year of great activity and productivity despite the backdrop of the pandemic. CRISPR Gene Editing Inventors Win Nobel Prize.

Life Science 111

Life Science Vaccination Vaccine Gene 111